These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
476 related articles for article (PubMed ID: 29282036)
21. MicroRNA-215 as a Diagnostic Marker in Egyptian Patients with Hepatocellular Carcinoma. El Mahdy HA; Abdelhamid IA; Amen AI; Abdelsameea E; Hassouna MM Asian Pac J Cancer Prev; 2019 Sep; 20(9):2723-2731. PubMed ID: 31554369 [TBL] [Abstract][Full Text] [Related]
22. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. Qi P; Cheng SQ; Wang H; Li N; Chen YF; Gao CF PLoS One; 2011; 6(12):e28486. PubMed ID: 22174818 [TBL] [Abstract][Full Text] [Related]
23. Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function. Okajima W; Komatsu S; Ichikawa D; Miyamae M; Kawaguchi T; Hirajima S; Ohashi T; Imamura T; Kiuchi J; Arita T; Konishi H; Shiozaki A; Moriumura R; Ikoma H; Okamoto K; Taniguchi H; Itoh Y; Otsuji E Oncotarget; 2016 Aug; 7(33):53820-53836. PubMed ID: 27462777 [TBL] [Abstract][Full Text] [Related]
24. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma. Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228 [TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma. Yu B; Zhou S; Liang H; Ye Q; Wang Y Dig Dis Sci; 2022 Jun; 67(6):2283-2292. PubMed ID: 33982217 [TBL] [Abstract][Full Text] [Related]
26. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma. Shaker O; Alhelf M; Morcos G; Elsharkawy A Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737 [TBL] [Abstract][Full Text] [Related]
27. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293 [TBL] [Abstract][Full Text] [Related]
30. Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms. Sayed GI; Solyman M; El Gedawy G; Moemen YS; Aboul-Ella H; Hassanien AE Sci Rep; 2024 Feb; 14(1):4989. PubMed ID: 38424116 [TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs for the diagnosis of hepatocellular carcinoma. Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930 [TBL] [Abstract][Full Text] [Related]
32. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma. Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561 [TBL] [Abstract][Full Text] [Related]
33. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis. Peng C; Li Z; Xie Z; Wang Z; Ye Y; Li B; Li W BMC Gastroenterol; 2020 Jul; 20(1):249. PubMed ID: 32736604 [TBL] [Abstract][Full Text] [Related]
34. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma. Fang Y; Yan D; Wang L; Zhang J; He Q J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610 [TBL] [Abstract][Full Text] [Related]
35. MicroRNAs as a novel class of diagnostic biomarkers in detection of hepatocellular carcinoma: a meta-analysis. Yin H; Peng X; Ren P; Cheng B; Li S; Qin C Tumour Biol; 2014 Dec; 35(12):12317-26. PubMed ID: 25204672 [TBL] [Abstract][Full Text] [Related]
36. Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma. Chen Y; Chen J; Liu Y; Li S; Huang P Med Sci Monit; 2015 Jun; 21():1864-71. PubMed ID: 26119771 [TBL] [Abstract][Full Text] [Related]
37. Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection. Fouda MS; Omran MM; Tarek G; Hady A Abdel Wahab A Arab J Gastroenterol; 2021 Mar; 22(1):28-33. PubMed ID: 33268243 [TBL] [Abstract][Full Text] [Related]
38. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. Zhang YC; Xu Z; Zhang TF; Wang YL World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392 [TBL] [Abstract][Full Text] [Related]
39. Systematic Review and Meta-Analysis: Circulating miRNAs for Diagnosis of Hepatocellular Carcinoma. Huang JT; Liu SM; Ma H; Yang Y; Zhang X; Sun H; Zhang X; Xu J; Wang J J Cell Physiol; 2016 Feb; 231(2):328-35. PubMed ID: 26291451 [TBL] [Abstract][Full Text] [Related]
40. Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma. An Y; Gao S; Zhao WC; Qiu BA; Xia NX; Zhang PJ; Fan ZP World J Gastroenterol; 2018 Jun; 24(24):2596-2604. PubMed ID: 29962816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]